Science and Discovery

Sanofi

1 article

A young child with a hopeful expression, representing the approval of Sanofi's Tzield drug for pediatric type 1 diabetes treatment.
Cosmos & Space

Sanofi diabetes drug Tzield now approved for children

The U.S. Food and Drug Administration has approved Sanofi's Tzield injection for children aged 8 and above with newly diagnosed stage 3 type 1 diabetes. This marks the first opportunity to slow the lo

Aram Sarkisian·June 14, 2026